Drug Repurposing: New Treatments for Zika Virus Infection?
- PMID: 27692879
- DOI: 10.1016/j.molmed.2016.09.006
Drug Repurposing: New Treatments for Zika Virus Infection?
Abstract
To date, no antiviral agents have been approved for treating Zika virus (ZIKV) infection. Two recent drug-repurposing studies published in Cell Host & Microbe and Nature Medicine demonstrated that screening FDA-approved drugs for antiviral activity is a promising strategy for identifying therapeutics with novel activity against ZIKV infection.
Keywords: Zika virus; antiviral; drug repurposing; mechanism-of-action.
Copyright © 2016 Elsevier Ltd. All rights reserved.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
